Gallegos JF, Fuentes A, Arroyo C, Minauro G, Hernández M, Arias H

Language: Spanish
References: 20
Page: 175-178
PDF size: 91.48 Kb.

ABSTRACT

Introduction: Although the possibility of developing cervical node metastases (CNM) in patients with squamous cell carcinoma of the larynx (SCCL) depends on the site of tumor origin, other factors may be associated, even in glottic tumors. The objective of this study was to determine factors associated with CNM.
Methods: We carried out a retrospective analysis of a series of patients with SCCL. We analyzed the following variables: T-staging, tumor site, and arytenoid-mobility/fixation. and correlated them with histopathological node status. Statistical significance was assessed using χ² tests.
Results: 91 patients were included. 82 were male and 9 female; median age was 66 years. The most frequently affected site was the glottic-subglottic region (38) followed by the glottis (22). The most frequent T stage was T3 (46%) followed by T4 (25%); 81% were N0 and 19% N+. 76 (83%) had arytenoid fixation. Factors associated with CNM included glottic-supraglottic infiltration (65%) and arytenoid fixation (17% vs. 0, p = 0.048). None of the patients with arytenoid mobility had CNM. Tumor infiltration to thyroid gland was observed among 14% of patients studied. The most important risk factor was subglottic extension (17%; p = 0.5).
Conclusions: Lack of mobility of the arytenoid cartilage is a factor associated with CNM among SCCL patients. A subglottic tumor is a risk factor for thyroid infiltration.

REFERENCES

1. Gallegos-Hernández JF, Martínez-Gómez H, Flores-Díaz R. La disecciónradical de cuello en el cáncer de vías aero-digestivas superiores (VADS). Indicaciones, extensión y radicalidad. Cir Ciruj 2002;70:369-376.

2. Andersen P, Cambronero F, Shaha AR, Shah JP. The extent of neck disease alter regional failure Turing observation of N0 neck. Am J Surg 1996;172:689-691.

3. Lefebvre JL, Buisset E, Coche-Dequeant B, Van JT, Prevost B, Hecquet B, et al. Epilarynx: pharynx or larynx. Head Neck 1995;17:377-381.

4. Yüce I, Caðlý S, Bayram A, Güney E. Occult metastases from T1-2 supraglottic carcinoma: role of primary tumor localization. Eur Arch Otorhinolaryngol 2009;266:1301-1304.

5. Robbins KT, Shaha AR, Medina JE, Califano JA, Wolf GT, Ferlito A. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head and Neck Surg 2008;134:536-538.

6. American Joint Committee on Cancer. Cancer Staging Manual. TNM Staging System for the Larynx. V.2.2008. Sixth edition. US: AJCC; 2002.

7. Genden EM, Ferlito A, Rinaldo A, Silver CE, Fagan JJ, Suárez C. Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck 2008;30:103-110.

8. Hagikyan ND, Bastian RW. Surgical therapy of glottic and subglottic tumors. En: Tawley SE, Panje WR, Batsakis JG, Lindberg RD. editores. Comprehensive management of head and neck tumors. Phyladelphia: Saunders; 1999. pp. 1039-1068.

9. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Head and neck cancers. Laryngeal Cancer V.1.2010.

10. Ganly I, Patel SG, Matsuo J, Sing B, Kraus DH, Boyle J. Predictor of outcome for advanced-stage supraglottic laryngeal cancer. Head and Neck 2009;31:1489-1495.

11. Zhang B, Xu ZG, Tang PZ. Elective lateral neck dissection for laryngeal cancer in the clinically negative neck. J Surg Oncol 2006;93:464-467.

12. Reidenbach MM. Topographical anatomy and oncologic implications of the anterolateral surface of the arytenoid cartilage. Eur Arch Otorhinolaringol 1998;255:140-142.

13. Reidenbach MM. The attachements of the conus elasticus to the laryngeal skeleton; physiologic and clinical implications. Clin Anat 1996;9:363-370.

14. Kirchner JA. Two hundred laryngeal cancers; patterns of growth and spread as seen in serial sections. Laryngoscope 1977;87:474-482.

15. Wang RC. Three-dimensional analysis of cricoarytenoid joint motion. Laryngoscope 1998;108:1-17.

16. Hirano M, Kurita S, Matsuoka H, Tateishi M. Vocal fold fixation in laryngeal carcinomas. Acta Otolaryngol 1991;111:449-454.

17. Dagan, Morris CG, Bennett JA, Mancuso AA, Amdur RJ, Hinerman RW et al. Prognostic significance of paraglottic space invasion in T2N0 carcinoma. Am J Clin Oncol 2007;30:186-190.

18. Lefebvre JL, Ang KK. Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations. A consensus panel summary. Int J Radiat Oncol Biol Phys 2009;73:1293-1303.

19. Gallegos HJF. Tratamiento actual del cáncer de laringe. Acta Med 2008;6:154- 157.

20. Brasnu D, Menard M, Fabre A, Janot F, Laccourreye H. Partial spracricoid laryngectomies: techniques, indications and results. J Otolaryngol 1988;17:173- 178.